Master of None, the new Netflix TV show created by Aziz Ansari and Alan Yang (best known for their work […]
Master of None, the new Netflix TV show created by Aziz Ansari and Alan Yang (best known for their work […]
When I was 18, I attended a large gathering of evangelical Christians, just as I had every summer through high […]
“So what do you do?” We all have asked this familiar question while making small talk at a BBQ, a […]
Ever heard of Hypoactive Sexual Desire Disorder (HSDD)? It’s a new “disease” distressing tens of thousands of (presumably straight) women. […]
By Elizabeth Reis
Students at Mt. Holyoke College are protesting the annual performance of Eve Ensler’s feminist classic, The Vagina Monologues. Their gripe with the play is that by focusing on vaginas, the play perpetuates “vagina essentialism,” suggesting that ALL women have vaginas and that ALL people with vaginas are women. Transgender and intersex people have taught us that this seemingly simple “truth” is actually not true. There are women who have penises and there are men who have vaginas. Not to mention women born without vaginas! Hence, these Mt. Holyoke critics imply, the play contributes to the erasure of difference by presenting a “narrow perspective on what it means to be a woman,” and shouldn’t be produced on college campuses.
In the United States, female circumcision (the removal of the clitoral hood) and clitoridectomy (the removal of the external nub […]
By Ian Lekus
The first I learned of PrEP, or pre-exposure prophylaxis, came from the signs and postcards around Fenway Health, Boston’s LGBT community health center. Those advertisements appeared as Fenway served as one of two U.S. research sites for PrEP, in advance of the U.S. Food and Drug Administration approving Truvada in July 2012 as the first drug deemed safe and effective for reducing the risk of HIV transmission.[1] As I started learning more, I quickly discovered how its advocates frequently compare PrEP to oral contraceptives. One PrEP researcher I consulted with early on in my investigations explicitly drew the parallel to her decision to use the Pill a few years earlier. Some of the similarities jump out immediately: for example, like oral contraceptives, PrEP — a pill taken daily to prevent HIV infection — separates prevention from the act of sexual intercourse itself.
By Jenna Tucker
I grew up in a culture obsessed with sexual ethics. As part of a group of Christian teenagers in the Midwest in the 1990’s, one thing we all knew, for certain, was that our religious and moral identities were directly linked to our relationships to sex. It was the culture that birthed virginity pledges and organized for abstinence-only sex education. I remember going to one of those Protestant mega-gatherings with youth groups from all over the country. The speaker gave us two messages that I carry with me to this day. The first was that we had to stop relying on our parents’ beliefs and develop our own relationship to God. The second was that we should not have sex and that anything that gave us sexual pleasure was sex. He was trying to head off our questions. Sex was bad, but what was sex? Could we have sex that didn’t risk pregnancy? Could we masturbate? What if we were engaged?
A year ago June, the United States Supreme Court published its decision in the case of United States v. Windsor, […]
by Nicole Foti
You may have noticed the recent hype surrounding the “little pink pill” or “pink Viagra,” a pill used to treat female sexual dysfunction, or FSD, a condition affecting nearly 50 million women nationwide. The FDA’s latest rejection of the drug flibanserin has caught the attention of a number of media outlets and women’s groups, including the National Organization for Women (NOW), who are questioning the motives behind this decision. Why does the FDA refuse to approve any drugs for women with sexual dysfunction, while men have five to choose from, plus another nineteen generic brands of these drugs? After reading many articles indicating that FSD was, in fact, an epidemic affecting millions of women (possibly myself included) and that the FDA was being outright sexist in their reluctance to approve drugs to treat it, I decided to do a little research. Instead of finding answers though, I seem to be left with questions. One in particular is: what are we treating here anyways?
When our Patreon gets to $500/month, we’ll be able to compensate our writers. This has been a long-term goal of Nursing Clio; now you can help us reach it! If you enjoy our content, support us and our writers by becoming a member of our Patreon.